Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Doxycycline DOT for STI Prevention in Kenyan Women on PrEP
NCT06582966Phase 4Completed
- Sponsor
- University of Washington
- Start
- Aug 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in sexually transmitted infection (STI), sponsored by University of Washington. Started Aug 2024; status: completed.
02
Drugs
doxycycline
03
Conditions
sexually transmitted infection (STI)
Beyond the preview
Go deeper on NCT06582966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06582966.